-
Posted by
Two Blokes May 22, 2025 -
Filed in
Stock
-
4 views
Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer's disease to the French pharmaceutical company's pipeline.
